Reporting of harms in clinical trials of esketamine in depression: A systematic review

被引:0
|
作者
De laportaliere, T. Taillefer [1 ]
Jullien, A. [2 ]
Yrondi, A. [3 ]
Cestac, P. [2 ]
Montastruc, F. [1 ]
机构
[1] CHU Toulouse, Serv Pharmacol Med & Clin, Toulouse, France
[2] CHU Toulouse, Dept Pharmacie, Toulouse, France
[3] CHU Toulouse, Serv Psychiat Med, Toulouse, France
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
CO-034
引用
收藏
页码:27 / 27
页数:1
相关论文
共 50 条
  • [21] Definition, reporting, and interpretation of composite outcomes in clinical trials: systematic review
    Cordoba, Gloria
    Schwartz, Lisa
    Woloshin, Steven
    Bae, Harold
    Gotzsche, Peter C.
    BMJ-BRITISH MEDICAL JOURNAL, 2010, 341 : 381
  • [22] Reporting and Analyzing Race and Ethnicity in Orthopaedic Clinical Trials: A Systematic Review
    Paul, Ryan W.
    Lee, Donghoon
    Brutico, Joseph
    Tjoumakaris, Fotios P.
    Ciccotti, Michael G.
    Freedman, Kevin B.
    JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS GLOBAL RESEARCH AND REVIEWS, 2021, 5 (05):
  • [23] Reporting on invasive lobular breast cancer in clinical trials: a systematic review
    Van Baelen, Karen
    Van Cauwenberge, Josephine
    Maetens, Marion
    Beck, Gabriela
    Camden, Ann
    Chase, Megan-Claire
    Fraser, Valerie
    Freeney, Siobhan
    Hutcheson, Laurie
    Levine, Julia K.
    Lien, Tone
    Terveer, Rian
    Turner, Claire
    Senkus, Elzbieta
    Jankowitz, Rachel C.
    Vandecaveye, Vincent
    Floris, Giuseppe
    Neven, Patrick
    Wildiers, Hans
    Sawyer, Elinor
    Vincent-Salomon, Anne
    Derksen, Patrick W. B.
    Desmedt, Christine
    NPJ BREAST CANCER, 2024, 10 (01)
  • [24] Evidence for the Selective Reporting of Analyses and Discrepancies in Clinical Trials: A Systematic Review of Cohort Studies of Clinical Trials
    Dwan, Kerry
    Altman, Douglas G.
    Clarke, Mike
    Gamble, Carrol
    Higgins, Julian P. T.
    Sterne, Jonathan A. C.
    Williamson, Paula R.
    Kirkham, Jamie J.
    PLOS MEDICINE, 2014, 11 (06) : 1 - 22
  • [25] Esketamine for treatment-resistant depression: A review of clinical evidence (Review)
    Vasiliu, Octavian
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2023, 25 (03)
  • [26] Opportunities for selective reporting of harms in randomized clinical trials: Selection criteria for non-systematic adverse events
    Mayo-Wilson, Evan
    Fusco, Nicole
    Hong, Hwanhee
    Li, Tianjing
    Canner, Joseph K.
    Dickersin, Kay
    TRIALS, 2019, 20 (01)
  • [27] Opportunities for selective reporting of harms in randomized clinical trials: Selection criteria for non-systematic adverse events
    Evan Mayo-Wilson
    Nicole Fusco
    Hwanhee Hong
    Tianjing Li
    Joseph K. Canner
    Kay Dickersin
    Trials, 20
  • [28] The association between stage of treatment-resistant depression and clinical utility of ketamine/esketamine: A systematic review
    Levinta, Anastasia
    Meshkat, Shakila
    McIntyre, Roger S.
    Ho, Cameron
    Lui, Leanna M. W.
    Lee, Yena
    Mansur, Rodrigo B.
    Teopiz, Kayla M.
    Rodrigues, Nelson B.
    Di Vincenzo, Joshua D.
    Ceban, Felicia
    Rosenblat, Joshua D.
    JOURNAL OF AFFECTIVE DISORDERS, 2022, 318 : 139 - 149
  • [29] Reporting of harms data in RCTs: a systematic review of empirical assessments against the CONSORT harms extension
    Hodkinson, Alex
    Kirkham, Jamie J.
    Tudur-Smith, Catrin
    Gamble, Carrol
    BMJ OPEN, 2013, 3 (09):
  • [30] Race reporting and disparities regarding clinical trials in bladder cancer: a systematic review
    Freudenburg, Elliott
    Bagheri, Iyla
    Srinivas, Sunay
    Martinez, Ariza
    Putluri, Nagireddy
    Klaassen, Zachary
    Kamat, Ashish M.
    Konety, Badrinath R.
    Kim, William Y.
    Dyrskjot, Lars
    McConkey, David J.
    Freedland, Stephen J.
    Black, Peter C.
    Daneshmand, Siamak
    Catto, James W. F.
    Williams, Stephen B.
    CANCER CAUSES & CONTROL, 2022, 33 (08) : 1071 - 1081